Silexion Therapeutics Corp

SLXN

$1.83

▲ +1.7% Today

as of Aug 5, 16:54 ET

Last 30 days -34.55% Jun 26 → Aug 05

Open

—

High

—

Low

—

Volume

—

Avg Vol

—

Mkt Cap

$2M

P/E (TTM)

—

Beta

—

52w High

—

52w Low

—

Div Yield

—

Shares Out

—

Recent Press Releases & News last 60 days · 4 items

Aug 4 · 13:15 PR GlobeNewswire

Silexion Therapeutics Reports New Positive Preclinical Findings Demonstrating Multi-Mechanism Immune Sensitization by SIL204 in KRAS-Driven Cancers

Jul 29 · 11:00 PR GlobeNewswire

Silexion Therapeutics Successfully Initiates Phase 2/3 Clinical Trial of SIL204 in Locally Advanced Pancreatic Cancer at Tel Aviv Sourasky Medical Center

Jun 23 · 12:40 PR GlobeNewswire

Silexion Therapeutics Receives Approval from Germany's BfArM to Initiate Phase 2/3 Clinical Trial of SIL204 in Locally Advanced Pancreatic Cancer

▸ Show all 4 press releases & news Free account →

Overview

52-week range

—

Avg surprise (last 0)

—

Avg reaction (last 0)

—

Earnings trends

EPS — actual vs estimate Actual Estimate

Earnings history

Date	Period	Actual EPS	Est	Surprise	YoY %Δ	Day react	Source
Tue Aug 12, 2025	Jun/2025	$-4.32	—	—	—	—	earnings

Upcoming

Date	Fiscal	Time	EPS Est	LY EPS	YoY %Δ
Tue Aug 11, 2026	Jun/2026	OTHER	—	-$43.20

Implied volatility — last 90 days

No IV snapshots yet for SLXN.

IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.

View on Nasdaq ↗